Kronos Bio, Inc. (KRON) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-05-19	Dec-31-18	Dec-05-18
	10-K	10-K	10-K	10-K	S-1/A	10-K	S-1/A
Revenues	0.0	0.0	0.0	0.0	13.4	0.0	5.0
Revenue growth					167.2%
Cost of goods sold	0.0	0.0	0.0	0.0	16.8	0.0	6.6
Gross profit	0.0	0.0	0.0	0.0	-3.4	0.0	-1.6
Gross margin					-25.1%		-32.0%
Selling, general and administrative [+]	43.4	38.5	14.8	3.4	3.4	1.6	1.6
General and administrative	43.4	38.5	14.8	3.4	3.4	1.6	1.6
Research and development	93.7	112.9	43.3	13.4		5.0
Other operating expenses					10.1		3.4
EBITDA [+]	-134.8	-149.4	-57.2	-16.5	-16.5	-6.6	-6.6
EBITDA growth	-9.8%	161.2%	247.5%	151.1%	151.1%
EBITDA margin					-122.4%		-130.2%
Depreciation and amortization	2.3	2.0	0.8	0.4	0.4	0.1	0.1
EBIT [+]	-137.1	-151.4	-58.0	-16.8	-16.8	-6.6	-6.6
EBIT growth	-9.4%	160.8%	245.2%	153.1%	153.1%
EBIT margin					-125.1%		-132.0%
Interest income, net [+]	3.9	0.3	-3.0	0.7	0.7	-0.1	-0.1
Interest expense			3.9	0.0		0.1	0.1
Interest income	3.9	0.3	0.9	0.7	0.7
Other income (expense), net			-27.4
Pre-tax income	-133.2	-151.1	-88.4	-16.1	-16.1	-6.7	-6.7
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-133.2	-151.1	-88.4	-16.1	-16.1	-6.7	-6.7
Net margin					-119.9%		-133.5%

Basic EPS [+]	($2.37)	($2.76)	($5.43)	($3.05)	($3.05)	($1.38)	($1.38)
Growth	-14.1%	-49.2%	78.0%	120.6%	120.6%
Diluted EPS [+]	($2.37)	($2.76)	($5.43)	($3.05)	($3.05)	($1.38)	($1.38)
Growth	-14.1%	-49.2%	78.0%	120.6%	120.6%

Shares outstanding (basic) [+]	56.2	54.8	16.3	5.3	5.3	4.9	4.9
Growth	2.6%	236.4%	208.4%	8.7%	8.7%
Shares outstanding (diluted) [+]	56.2	54.8	16.3	5.3	5.3	4.9	4.9
Growth	2.6%	236.4%	208.4%	8.7%	8.7%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.